Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib may effectively treat folliculitis decalvans.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

TCDD changes skin cell growth and keratin production in mice.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.